Target intelligence / Profile preview

Proteinase-activated receptor 2 (PAR-2) (PAR-2)

Target
PAR-2
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Proteinase-activated receptor 2 (PAR-2), encoded by the F2RL1 gene, is a class A G protein-coupled receptor that acts as a cell-surface sensor for extracellular serine proteases such as trypsin, tryptase, and coagulation factors VIIa and Xa. Unlike typical GPCRs, PAR-2 is activated through proteolytic cleavage of its extracellular N-terminus, which exposes a tethered ligand that binds intramolecularly to initiate intracellular signaling cascades, including Gαq, Gα12/13, and β-arrestin pathways. It plays a critical role in mediating inflammatory responses, pain transmission (nociception), and tissue remodeling. In disease states, PAR-2 is heavily implicated in chronic inflammatory conditions like asthma, rheumatoid arthritis, and inflammatory bowel disease, as well as in cancer progression, metastasis, and resistance to immunotherapies. Therapeutic strategies targeting PAR-2 include monoclonal antibodies (such as MEDI0618) and small-molecule negative allosteric modulators (such as DT-9046 and I-117) designed to block its activation and alleviate chronic pain, migraine, and tumor immune evasion.

Other names
F2RL1Coagulation factor II receptor-like 1G-protein coupled receptor 11GPR11Thrombin receptor-like 1F2R-like trypsin receptor 1
02

Mechanism of action

Negative allosteric modulation, competitive antagonism, and monoclonal antibody-mediated blockade of the extracellular cleavage site or tethered ligand binding.

03

Biological functions

Signal transductionImmune responseInflammatory responseCell migrationNociception
04

Disease associations

InflammationCancerCardiovascular diseaseAsthmaOsteoarthritisRheumatoid arthritisMigrainePain
05

Safety considerations

Impaired epithelial barrier integrityAltered tissue repair and wound healingPotential for cardiovascular side effects (e.g., heart failure susceptibility)Risk of systemic thromboinflammationOpposing compartmental effects (blockade may be counterproductive where PAR-2 sustains antitumour immunity)
06

Interacting drugs

12 more in the full profile.

07

Biomarkers

PRO-PAR2F2RL1 mRNA expressionActivated PAR-2 levels

Beyond the preview

Go deeper on Proteinase-activated receptor 2 (PAR-2) (PAR-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteinase-activated receptor 2 (PAR-2) (PAR-2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call